BridgeBio Pharma, Inc. (BMV:BBIO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Fred Hassan Other companies: Recursion Pharmaceuticals, Inc. (Director · Since Oct 31, 2026); EyePoint, Inc. (Director · Since at least Sep 3, 2024); Cocrystal Pharma, Inc. (Director · Since at least Apr 20, 2023); Precigen, Inc. (Director · Since at least Jun 30, 2016); Prometheus Biosciences Inc (Director · May 14, 2021 – Jun 16, 2023 · Past); Time Warner Inc (Director · Jun 1, 2016 – Jun 14, 2018 · Past); Amgen Inc. (Director · Jul 28, 2015 – May 5, 2020 · Past) | Director · Since at least Aug 17, 2021 |
| Brent Saunders Other companies: Bausch + Lomb Corporation (Chairman of the Board and CEO, Director · Since at least Mar 6, 2023); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); SkinHealth Systems Inc. (Chairman · Since at least Sep 29, 2020); Cisco Systems, Inc. (Director · Mar 13, 2017 – Dec 8, 2022 · Past); Forest Laboratories Inc (CEO & President, Director · Aug 23, 2011 – Jun 30, 2014 · Past); Merck & Company, Inc. (Senior Vice President · May 19, 2006 – Nov 3, 2009 · Past) | Director · Jun 23, 2020 – Jun 22, 2022 · Past |
| Richard H. Scheller Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Alector, Inc. (Board Member · Since at least Feb 6, 2019); 23Andme Holding Co (Director · Jun 16, 2021 – Aug 26, 2024 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – May 20, 2021 · Past); Xenon Pharmaceuticals Inc. (Director · Mar 16, 2015 – Sep 16, 2019 · Past); Genentech Inc (EVP-RESEARCH · Jan 13, 2006 – Mar 26, 2009 · Past) | Director · Jun 27, 2019 – Feb 16, 2023 · Past |
| Charles Homcy Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Population Health Investment Co Inc (Director · Nov 17, 2020 – Jan 26, 2021 · Past); Pliant Therapeutics, Inc. (Director · Jun 2, 2020 – Jun 29, 2021 · Past); Portola Pharmaceuticals Inc (Director · Jun 8, 2018 – Jan 2, 2019 · Past); Global Blood Therapeutics Inc (Director · Oct 3, 2017 – Jun 20, 2018 · Past) | Director · Since at least Jun 27, 2019 |
| Ali J Satvat Other companies: Coherus Oncology, Inc. (Director · Since at least Nov 6, 2014); Impel Neuropharma Inc (Director · Apr 22, 2021 – Apr 22, 2021 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – Jan 26, 2021 · Past); PRA Health Sciences Inc (Director · Nov 12, 2014 – Nov 12, 2014 · Past) | Director · Since at least Jun 27, 2019 |
| Cameron Turtle Other companies: Damora Therapeutics, Inc. (Board Director · Since at least Mar 23, 2026); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Spyre Therapeutics, Inc. (Chief Executive Officer · Since at least Jun 22, 2023); Eidos Therapeutics Inc (Chief Business Officer · Nov 5, 2018 – Jan 26, 2021 · Past) | See Remarks · Jun 27, 2019 – Dec 28, 2020 · Past |
| Frank McCormick Other companies: BridgeBio Oncology Therapeutics, Inc. (Director · Since at least Aug 11, 2025); Olema Pharmaceuticals, Inc. (Director · Sep 18, 2020 – Nov 23, 2020 · Past); Aduro Biotech Inc (Director · Apr 14, 2015 – Jun 6, 2018 · Past); Exelixis, Inc. (Director · May 2, 2006 – Dec 6, 2013 · Past) | Director · Since at least Jun 27, 2019 |
| Douglas A Dachille Other companies: PNC Financial Services Group, Inc. (the) (Director · Since at least Feb 3, 2025); Equitable Holdings, Inc. (Director · Since at least Jan 15, 2025); American International Group, Inc. New (EVP and CIO · Sep 30, 2015 – Jun 29, 2021 · Past) | Director · Since at least Aug 17, 2021 |
| Michael Henderson Other companies: Apogee Therapeutics, Inc. (Chief Executive Officer · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Board Member · Since at least Jun 22, 2023); ARYA Sciences Acquisition IV Corp (Director · Feb 25, 2021 – Jul 31, 2024 · Past) | Chief Business Officer · Jun 27, 2019 – Dec 15, 2020 · Past |
| Andrew Lo Other companies: AbCellera Biologics Inc. (Director · Since at least Dec 3, 2021); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Sep 15, 2022 · Past) | Director · Since at least Jun 23, 2020 |
| Brian M Stolz Other companies: Activision Blizzard Inc (Chief People Officer · May 31, 2016 – May 30, 2019 · Past); Bausch Health Companies Inc. (EVP, Administration & CHCO · Jul 20, 2013 – Jun 22, 2015 · Past) | Chief Operating Officer · Oct 9, 2019 – Aug 16, 2020 · Past |
| BridgeBio Pharma Other companies: Maze Therapeutics, Inc. (Director · Since at least Mar 25, 2026); Sensei Biotherapeutics, Inc. (Chief Financial Officer · Jun 15, 2026 – Nov 5, 2026 · Past) | Executive Chairman by the Board of Directors · Since at least Apr 22, 2026 |
| Hannah Valantine Other companies: CareDx, Inc. (Director · Since at least Jul 1, 2021); Pacific Biosciences of California, Inc. (Director · Since at least Jun 16, 2021) | Director · Since at least Oct 23, 2021 |
| James Momtazee Other companies: Roivant Sciences Ltd. (Nominating and Governance Committee Member · Since at least Oct 1, 2021); PRA Health Sciences Inc (Director · Aug 13, 2019 – Jul 1, 2021 · Past) | Director · Since at least Jun 27, 2019 |
| Jennifer E. Cook Other companies: Denali Therapeutics Inc. (Director · Since at least May 31, 2024); Jazz Pharmaceuticals plc (Director · Since at least Dec 4, 2023) | Director · Since at least Jun 21, 2024 |
| Neil Kumar Other companies: Maze Therapeutics, Inc. (Director · Since at least Mar 27, 2026); BridgeBio Oncology Therapeutics, Inc. (Executive Chairman · Since at least Aug 11, 2025) | Chief Executive Officer, Director · Since at least Nov 16, 2023 |
| Brian Stephenson Other companies: Sensei Biotherapeutics, Inc. (Chief Financial Officer · Since at least Nov 5, 2026) | CFO and Treasurer · Nov 16, 2020 – Feb 25, 2025 · Past |
| Eric Aguiar Other companies: Biomea Fusion, Inc. (Director · Since at least Jun 12, 2024) | Director · Since at least Jun 21, 2024 |
| Pedro J. Beltran Other companies: BridgeBio Oncology Therapeutics, Inc. (Chief Executive Officer · Since at least Aug 11, 2025) | Chief Executive Officer, Idan Elmelech as Chief Operating Officer · Since at least Apr 22, 2026 |
| Randal W Scott Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026) | Director · Since at least Dec 1, 2023 |
| Alex Fideler | Executive Director · Since at least Nov 4, 2026 |
| Andrea Ellis | Director · Since at least Aug 17, 2021 |
| Brian Koertgen | CTO · Since at least Nov 4, 2026 |
| Bubba Murarka | Executive Vice President · Since at least Mar 11, 2026 |
| Caleb Tripp | Chief Financial Officer · Feb 28, 2025 – Nov 4, 2026 · Past |
| Chinmay Shukla | Senior Vice President · Since at least Mar 30, 2026 |
| ContactKaitlyn Reilly | Director · Since at least Oct 5, 2026 |
| ContactKristen Kelleher | Director · Since at least Oct 5, 2026 |
| Daniel Hong | Director · Since at least Nov 5, 2026 |
| Daniel Nickle | Chief Legal Officer · Since at least Nov 4, 2026 |
| Hassan Jaroudi | Director of Finance · Since at least Nov 4, 2026 |
| Jeffrey Clarke | Director · Since at least Nov 5, 2026 |
| Kasia Gosek | Chief Strategy Officer · Since at least Nov 4, 2026 |
| Katherine Chang | Director · Since at least Nov 5, 2026 |
| Lilian Zhang | Director of Research · Since at least Nov 4, 2026 |
| Mandy Rohrig | Vice President of Operations · Since at least Nov 4, 2026 |
| Maricel Apuli | Chief Accounting Officer · Since at least Feb 19, 2025 |
| Natalie Henchcliffe | COO · Since at least Nov 4, 2026 |
| Reed Ashford | Director · Since at least Nov 5, 2026 |
| Robert Cheng | Executive Vice President · Since at least Nov 4, 2026 |
| Ronald J Daniels | Director · Since at least Jun 17, 2021 |
| Scott Yahiro | Chief Commercial Officer · Since at least Nov 4, 2026 |
| Thomas Trimarchi | President and CFO · Since at least Jul 23, 2024 |